Sepsis: a roadmap for future research

J Cohen, JL Vincent, NKJ Adhikari… - The Lancet infectious …, 2015 - thelancet.com
Sepsis is a common and lethal syndrome: although outcomes have improved, mortality
remains high. No specific anti-sepsis treatments exist; as such, management of patients …

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of …

PNA Harris, PA Tambyah, DL Paterson - The Lancet Infectious …, 2015 - thelancet.com
The spread of extended-spectrum β-lactamase (ESBL) genes in Enterobacteriaceae such as
Escherichia coli or Klebsiella spp is a major challenge to modern medical practice …

[PDF][PDF] Resistencia emergente a los antibióticos: una amenaza global y un problema crítico en el cuidado de la salud

C Rocha, ND Reynolds… - Revista Peruana de …, 2015 - SciELO Public Health
Después del desarrollo y la comercialización en masa de los antibióticos, las bacterias
patógenas y ambientales han desa-rrollado resistencia a los antibióticos desde el siglo …

[HTML][HTML] Distribución y caracterización molecular de betalactamasas en bacterias Gram negativas en Colombia, 2001-2016

AM Rada, C Hernández-Gómez, E Restrepo… - Biomédica, 2019 - scielo.org.co
Las betalactamasas, enzimas con capacidad hidrolítica frente a los antibióticos
betalactámicos, son responsables del principal mecanismo de resistencia en bacterias …

Resistance to quinolones, cephalosporins and macrolides in Escherichia coli causing bacteraemia in Peruvian children

N Palma, MJ Pons, C Gomes, J Mateu… - Journal of global …, 2017 - Elsevier
Objectives To characterise the β-lactam, quinolone and macrolide resistance levels and
mechanisms in 62 Escherichia coli isolates causing bacteraemia in Peruvian children …

Clinical management of infections caused by Enterobacteriaceae that express extended-spectrum β-lactamase and AmpC enzymes

PNA Harris - Seminars in respiratory and critical care medicine, 2015 - thieme-connect.com
The production of β-lactamase is the principal mechanism by which gram-negative bacteria
resist the action of β-lactam antibiotics. In recent decades, there has been an alarming …

Impact of sepsis classification and multidrug-resistance status on outcome among patients treated with appropriate therapy

JP Burnham, MA Lane, MH Kollef - Critical care medicine, 2015 - journals.lww.com
Objective: To assess the impact of sepsis classification and multidrug-resistance status on
outcome in patients receiving appropriate initial antibiotic therapy. Design: A retrospective …

Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the …

S Vega, MJ Dowzicky - Annals of clinical microbiology and antimicrobials, 2017 - Springer
Background The in vitro activity of tigecycline and comparator agents was evaluated against
Gram-positive and Gram-negative isolates collected in Latin American centers between …

Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses

TC Hendrik, AF Voor in 't holt, MC Vos - PLoS One, 2015 - journals.plos.org
Healthcare-related infections caused by extended-spectrum beta-lactamase (ESBL)-
producing Klebsiella spp. are of major concern. To control transmission, deep …

Sepsis: a threat that needs a global solution

FR Machado, LCP Azevedo - Critical care medicine, 2018 - journals.lww.com
Nonetheless, there are no high-quality data from LMICs that can allow a better estimation.
Most studies, especially those from low-income settings, are retrospective and single center …